Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.
Sequeiros T, García M, Montes M, Oliván M, Rigau M, Colás E, de Torres I, Morote J, Reventós J, Doll A. Sequeiros T, et al. Among authors: de torres i. Biomed Res Int. 2013;2013:283635. doi: 10.1155/2013/283635. Epub 2013 Nov 25. Biomed Res Int. 2013. PMID: 24371818 Free PMC article. Review.
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI).
Ribas A, Bellmunt J, Albanell J, De Torres I, Bermejo B, De Torres JA, Morote J, Gallardo E, Vera R, Carulla J, Sole-Calvo LA. Ribas A, et al. Among authors: de torres i, de torres ja. Tumori. 1996 Nov-Dec;82(6):554-9. doi: 10.1177/030089169608200608. Tumori. 1996. PMID: 9061063
Measurement of free PSA in the diagnosis and staging of prostate cancer.
Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J. Morote J, et al. Among authors: de torres i. Int J Cancer. 1997 May 29;71(5):756-9. doi: 10.1002/(sici)1097-0215(19970529)71:5<756::aid-ijc11>3.0.co;2-6. Int J Cancer. 1997. PMID: 9180142 Free article.
Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J. Morote J, et al. Among authors: de torres i. J Urol. 1997 Aug;158(2):502-4. J Urol. 1997. PMID: 9224333
Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR.
Schwartz S Jr, Caceres C, Morote J, De Torres I, Rodriguez-Vallejo JM, Gonzalez J, Reventos J. Schwartz S Jr, et al. Among authors: de torres i. Int J Cancer. 1998 May 18;76(4):464-7. doi: 10.1002/(sici)1097-0215(19980518)76:4<464::aid-ijc3>3.0.co;2-p. Int J Cancer. 1998. PMID: 9590118 Free article.
Androgen-independent basal cell re-epithelialization, c-erbB-2 mRNA expression and androgen-dependent EGFr mRNA expression in benign prostatic hyperplasia explant cultures treated with finasteride.
Schwartz S Jr, Caceres C, De Torres I, Morote J, Rodriguez-Vallejo JM, Gonzalez J, Reventos J. Schwartz S Jr, et al. Among authors: de torres i. Int J Cancer. 1998 May 18;76(4):519-22. doi: 10.1002/(sici)1097-0215(19980518)76:4<519::aid-ijc13>3.0.co;2-2. Int J Cancer. 1998. PMID: 9590128 Free article.
176 results